Global Long-term Asthma Control Medication Market Research Report 2025

Publication ID:

PB504250894

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Long-term Asthma Control Medication was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Long-term Asthma Control Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-term Asthma Control Medication.
The Long-term Asthma Control Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-term Asthma Control Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-term Asthma Control Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Mylan
GlaxoSmithKline
AstraZeneca
F. Hoffmann-La Roche
Merck & Co., Inc
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries
Lupin Pharmaceuticals
Novartis International AG
Sunovion Pharmaceuticals
Sanofi
Segment by Type
Inhaled Type
Oral Type
Intravenous Injection Type
Segment by Application
Hospital
Clinic
Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-term Asthma Control Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-term Asthma Control Medication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inhaled Type
1.2.3 Oral Type
1.2.4 Intravenous Injection Type
1.3 Market by Application
1.3.1 Global Long-term Asthma Control Medication Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-term Asthma Control Medication Market Perspective (2020-2031)
2.2 Global Long-term Asthma Control Medication Growth Trends by Region
2.2.1 Global Long-term Asthma Control Medication Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Long-term Asthma Control Medication Historic Market Size by Region (2020-2025)
2.2.3 Long-term Asthma Control Medication Forecasted Market Size by Region (2026-2031)
2.3 Long-term Asthma Control Medication Market Dynamics
2.3.1 Long-term Asthma Control Medication Industry Trends
2.3.2 Long-term Asthma Control Medication Market Drivers
2.3.3 Long-term Asthma Control Medication Market Challenges
2.3.4 Long-term Asthma Control Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-term Asthma Control Medication Players by Revenue
3.1.1 Global Top Long-term Asthma Control Medication Players by Revenue (2020-2025)
3.1.2 Global Long-term Asthma Control Medication Revenue Market Share by Players (2020-2025)
3.2 Global Long-term Asthma Control Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Long-term Asthma Control Medication Revenue
3.4 Global Long-term Asthma Control Medication Market Concentration Ratio
3.4.1 Global Long-term Asthma Control Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-term Asthma Control Medication Revenue in 2024
3.5 Global Key Players of Long-term Asthma Control Medication Head office and Area Served
3.6 Global Key Players of Long-term Asthma Control Medication, Product and Application
3.7 Global Key Players of Long-term Asthma Control Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-term Asthma Control Medication Breakdown Data by Type
4.1 Global Long-term Asthma Control Medication Historic Market Size by Type (2020-2025)
4.2 Global Long-term Asthma Control Medication Forecasted Market Size by Type (2026-2031)
5 Long-term Asthma Control Medication Breakdown Data by Application
5.1 Global Long-term Asthma Control Medication Historic Market Size by Application (2020-2025)
5.2 Global Long-term Asthma Control Medication Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Long-term Asthma Control Medication Market Size (2020-2031)
6.2 North America Long-term Asthma Control Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Long-term Asthma Control Medication Market Size by Country (2020-2025)
6.4 North America Long-term Asthma Control Medication Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-term Asthma Control Medication Market Size (2020-2031)
7.2 Europe Long-term Asthma Control Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Long-term Asthma Control Medication Market Size by Country (2020-2025)
7.4 Europe Long-term Asthma Control Medication Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long-term Asthma Control Medication Market Size (2020-2031)
8.2 Asia-Pacific Long-term Asthma Control Medication Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2020-2025)
8.4 Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long-term Asthma Control Medication Market Size (2020-2031)
9.2 Latin America Long-term Asthma Control Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Long-term Asthma Control Medication Market Size by Country (2020-2025)
9.4 Latin America Long-term Asthma Control Medication Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-term Asthma Control Medication Market Size (2020-2031)
10.2 Middle East & Africa Long-term Asthma Control Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2020-2025)
10.4 Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Long-term Asthma Control Medication Introduction
11.1.4 Boehringer Ingelheim Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Long-term Asthma Control Medication Introduction
11.2.4 Mylan Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.2.5 Mylan Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Long-term Asthma Control Medication Introduction
11.3.4 GlaxoSmithKline Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Long-term Asthma Control Medication Introduction
11.4.4 AstraZeneca Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Long-term Asthma Control Medication Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Merck & Co., Inc
11.6.1 Merck & Co., Inc Company Details
11.6.2 Merck & Co., Inc Business Overview
11.6.3 Merck & Co., Inc Long-term Asthma Control Medication Introduction
11.6.4 Merck & Co., Inc Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.6.5 Merck & Co., Inc Recent Development
11.7 Glenmark Pharmaceuticals
11.7.1 Glenmark Pharmaceuticals Company Details
11.7.2 Glenmark Pharmaceuticals Business Overview
11.7.3 Glenmark Pharmaceuticals Long-term Asthma Control Medication Introduction
11.7.4 Glenmark Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.7.5 Glenmark Pharmaceuticals Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Long-term Asthma Control Medication Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Lupin Pharmaceuticals
11.9.1 Lupin Pharmaceuticals Company Details
11.9.2 Lupin Pharmaceuticals Business Overview
11.9.3 Lupin Pharmaceuticals Long-term Asthma Control Medication Introduction
11.9.4 Lupin Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.9.5 Lupin Pharmaceuticals Recent Development
11.10 Novartis International AG
11.10.1 Novartis International AG Company Details
11.10.2 Novartis International AG Business Overview
11.10.3 Novartis International AG Long-term Asthma Control Medication Introduction
11.10.4 Novartis International AG Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.10.5 Novartis International AG Recent Development
11.11 Sunovion Pharmaceuticals
11.11.1 Sunovion Pharmaceuticals Company Details
11.11.2 Sunovion Pharmaceuticals Business Overview
11.11.3 Sunovion Pharmaceuticals Long-term Asthma Control Medication Introduction
11.11.4 Sunovion Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.11.5 Sunovion Pharmaceuticals Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Long-term Asthma Control Medication Introduction
11.12.4 Sanofi Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Boehringer Ingelheim
Mylan
GlaxoSmithKline
AstraZeneca
F. Hoffmann-La Roche
Merck & Co., Inc
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries
Lupin Pharmaceuticals
Novartis International AG
Sunovion Pharmaceuticals
Sanofi

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂